Julio Wainstein

ORCID: 0000-0002-2035-9243

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study”.

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Pancreatic Safety of Sitagliptin in the TECOS Study

UNC Libraries(2020)10.17615/7280-h844

N/A

0DataRank · unranked

0 citations

Yuliya Lokhnygina, Tsvetalina Tankova, Jennifer B. Green, Pablo Aschner, Keyur P. Patel +10 more